Ascite réfractaire Ascite réfractaire Arnaud Pauwels Service d ... - Afef

4. Gentilini P, Casini-Raggi V, Di Fiore G, et al. Albumin improve the response todiuretics in patients with cirrhosis and ascites : results of a randomized, controlledtrial. J Hepatol 1999; 30: 639-645.5. Spahr L, Villeneuve JP, Tran HK, Pomier-Layrargues G. Furosemide-inducednatriuresis as a test to identify cirrhotic patients with refractory ascites. Hepatology2001; 33: 28-31.6. Guardiola, J, Baliellas C, Xiol X, et al. External validation of a prognostic model forpredicting survival of cirrhotic patients with refractory ascites. Am J Gastroenterol2002; 97: 2374-2378.7. Ginès A, Planas R, Angeli P, et al. Treatment of patients with cirrhosis and refractoryascites using LeVeen shunt with titanium tip : comparison with therapeuticparacentesis. Hepatology 1995; 22: 124-131.8. Ochs A, Rössle M, Haag K, et al. The transjugular intrahepatic portosystemic stentshuntprocedure for refractory ascites. New Engl J Med 1995; 332: 1192-1197.9. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemicshunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: arandomized trial. J Hepatol 1996; 25: 135-144.10. Rössle M, Ochs A, Gülgerg V, et al. A comparison of paracentesis and transjugularintrahepatic portosytemic shunting in patients with ascites. New Engl J Med 2000;342: 1701-1707.11. Ginès P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shuntingversus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology2002; 123: 1839-1847.12. Sanyal AJ, Genning C, Redder KJ, et al. The North American Study for the treatmentof refractory ascites. Gastroenterology 2003; 124: 634-641.13. Gülberg V, Liss I, Bilzer M, et al. Improved quality of life in patients with refractoryascites or recidivant ascites after insertion of transjugular intrahepatic portosystemicshunts. Digestion 2002; 66: 127-130.14. Allard JP, Chau J, Sandokji K, et al. Effects of ascites resolution after successful TIPSon nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol 2001; 96:2442-2447.15. Ginès A, Fernandez-Esparrach G, Monescillo A, et al. Randomized trial comparingalbumin, dextran 70 and polygelin in cirrhotic patients with ascites treated withparacentesis. Gastroenterology 1996; 111: 1002-1010.16. Coll S, Vila MC, Molina L, et al. Mechanisms of early decrease in systemic vascularresistance after total paracentesis : influence of flow rate of ascites extraction. Eur JGastroenterol Hepatol 2004; 16: 347-353.17. Jeffries MA, Stern MA, Gunaratnam NT, Fontana RJ. Unsuspected infection isinfrequent in asymptomatic outpatients with refractory ascites undergoing therapeuticparacentesis. Am J Gastroenterol 1999; 94: 2972-2976.18. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairmentand mortality in patients with cirrhosis and spontaneous bacterial peritonitis. NewEngl J Med 1999; 341: 403-409.19. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practicein hospitalized cirrhotic patients. Results of a prospective study. Nutrition 2003; 19:515-521.20. Belghiti J, Durand F. Abdominal wall hernias in the setting of cirrhosis. Sem LiverDis 1997;17: 219-226.